VISENTIN, ANDREA

VISENTIN, ANDREA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 171 (tempo di esecuzione: 0.044 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 2025 Visentin A. + HEMATOLOGICAL ONCOLOGY - -
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia 2025 Cellini, AlessandroAngotzi, FrancescoRuocco, ValeriaPizzi, MarcoTrentin, LivioVisentin, Andrea + FRONTIERS IN HEMATOLOGY - -
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13) 2025 Eleonora RoncagliaEnrico GaffoGiulia CalabrettoFederica FrezzatoValeria RuoccoSilvia OrsiRoberto MerloAlberto CaregariIlias GlogovitisAlessandro CelliniFrancesco AngotziLivio TrentinAndrea VisentinStefania Bortoluzzi. + JOURNAL OF HEMATOLOGY & ONCOLOGY - -
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 2025 Visentin, AndreaTrentin, Livio + BLOOD ADVANCES - -
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms 2025 Trentin, LivioVisentin, Andrea + LEUKEMIA - -
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control Study 2025 Visentin, AndreaAngotzi, Francesco + BLOOD ADVANCES - -
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia 2025 Cellini, AlessandroAngotzi, FrancescoPiazza, FrancescoTrentin, LivioVisentin, Andrea + EXPERT REVIEW OF HEMATOLOGY - -
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD 2025 Visentin, AndreaCellini, Alessandro + LEUKEMIA & LYMPHOMA - -
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype 2025 Cellini, AlessandroAngotzi, FrancescoTrentin, LivioVisentin, Andrea + BRITISH JOURNAL OF HAEMATOLOGY - -
Peripheral Neuropathy and BTKis in Waldenström: A Response? 2025 Briani, ChiaraSalvalaggio, AlessandroVisentin, Andrea + BLOOD ADVANCES - -
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study 2025 Pizzi, MarcoFriziero, AlbertoBertozzi, IreneBinotto, GianniDei Tos, Angelo PaoloCeccato, JessicaCinetto, FrancescoPiazza, FrancescoVisentin, AndreaZambello, RenatoTrentin, LivioVianello, Fabrizio + JOURNAL OF CLINICAL MEDICINE - -
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice 2025 Visentin, Andrea + HAEMATOLOGICA - -
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 2025 Visentin, AndreaCellini, Alessandro + LEUKEMIA - -
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia 2025 Visentin, AndreaPiazza, Francesco + HEMASPHERE - -
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 2025 Cellini, AlessandroAngotzi, FrancescoTrentin, LivioVisentin, Andrea + BLOOD ADVANCES - -
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 2024 Sommaggio, RobertaCappuzzello, ElisaCatanzaro, DanielaChieregato, KatiaMerlo, AnnaPieta, Anna DallaTrentin, LivioVisentin, AndreaRosato, Antonio + HAEMATOLOGICA - -
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD 2024 Pizzi, MarcoCrimi', FilippoPiazza, FrancescoTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
CD23 expression in lymphoplasmacytic lymphoma: Clinical–pathological and biological correlations 2024 Pizzi, MarcoScapinello, GretaBertozzi, IreneArcidiacono, Gaetano ParideTrimarco, ValentinaVisentin, AndreaTrentin, LivioPiazza, FrancescoDei Tos, Angelo Paolo + HISTOPATHOLOGY - -
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 2024 Visentin, AndreaTrentin, Livio + HEMASPHERE - -
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course 2024 Pagnin, ElisaFrezzato, FedericaFacco, MonicaPiazza, FrancescoTrentin, LivioVisentin, Andrea + CANCERS - -